A federal report pointing out the benefits of COVID-19 vaccines may never be released, as it has been rejected from publication.

For older adults, longer and more frequent daytime napping was found to be associated with higher all-cause mortality.

Higher sodium intake may be linked to worsening cognitive function in men, according to results of a new study.

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

Patients with acromegaly face increased risks for overall cancer, lung and hematologic malignancies, and all-cause mortality.

A nine-protein APOL1 Proteomic Risk Score (APRS) enables accurate prediction of kidney disease progression in APOL1 high-risk individuals.

Hispanic patients exhibit higher thyroid malignancy rates than non-Hispanic patients despite similar TI-RADS and Bethesda scores.

Burosumab treatment is associated with improved long-term growth outcomes in children and adolescents with X-linked hypophosphatemia.

An umbrella review in JAMA Network Open finds low credibility for most noncardiometabolic effects of GLP-1RAs in clinical studies.

Higher intake of cereal- and fruit-based fiber is associated with a significantly lower risk for T2D and improved metabolic biomarkers.

Baseline osteoporosis and axial disease predicted higher odds of needing to switch therapies in pediatric chronic nonbacterial osteomyelitis.

Drug companies involved in price deals with President Trump have continued to raise prices on hundreds of medications.